Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-CINACALCET | 90MG | TABLET | Resolved | 2022-09-09 | 2022-10-07 | 169051 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-08-19 | 2022-10-14 | 167421 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2022-08-11 | 2022-10-14 | 166439 |
| APO-RIZATRIPTAN | 5MG | TABLET | Resolved | 2022-09-09 | 2022-10-14 | 169057 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-10-14 | 159719 |
| APO-LABETALOL | 100MG | TABLET | Resolved | 2022-09-30 | 2022-10-14 | 170804 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-09-09 | 2022-10-14 | 169048 |
| APO-MEMANTINE | 10MG | TABLET | Resolved | 2022-07-29 | 2022-10-14 | 165723 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-08-09 | 2022-10-20 | 166399 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2022-10-20 | 166601 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-11 | 2022-10-20 | 166445 |
| APO-BUSPIRONE | 10MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170109 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-10-07 | 2022-10-21 | 171417 |
| APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2022-07-29 | 2022-10-21 | 165730 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-04-29 | 2022-10-22 | 159722 |
| APO-ESOMEPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-01 | 2022-10-31 | 168364 |
| APO-RISPERIDONE | 0.25MG | TABLET | Resolved | 2022-07-29 | 2022-10-31 | 165674 |
| APO-RISPERIDONE | 0.50MG | TABLET | Resolved | 2022-07-05 | 2022-10-31 | 164083 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
| APO-QUETIAPINE | 25MG | TABLET | Discontinued | 2021-06-25 | 2021-06-25 | 141546 |
| APO-PINDOL TAB 5MG | 5MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154568 |
| APO-PINDOL TAB 10MG | 10MG | TABLET | Discontinued | 2022-02-09 | 2022-02-10 | 154571 |
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-CLOBETASOL SPRAY | 0.05% | SPRAY | Discontinued | 2022-09-06 | 2022-09-06 | 168648 |
| APO-PINDOL TAB 15MG | 15MG | TABLET | Discontinued | 2022-02-09 | 2022-12-09 | 154574 |
| APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-CARVEDILOL | 6.25MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217499 |
| APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
| APO-CARVEDILOL | 25MG | TABLET | Discontinued | 2024-01-26 | 2024-01-27 | 217504 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |